Get the Stockscreener App
118.97
10.46%
11.27
After Hours:
118.50
-0.47
-0.40%
Transmedics Group Inc stock is traded at $118.97, with a volume of 3.86M.
It is up +10.46% in the last 24 hours and down -11.22% over the past month.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
See More
Previous Close:
$107.70
Open:
$123.61
24h Volume:
3.86M
Relative Volume:
3.71
Market Cap:
$4.02B
Revenue:
$401.09M
Net Income/Loss:
$32.64M
P/E Ratio:
126.56
EPS:
0.94
Net Cash Flow:
$-120.51M
1W Performance:
+11.41%
1M Performance:
-11.22%
6M Performance:
+76.12%
1Y Performance:
-16.37%
1-Day Range:
$111.30
$124.50
1-Week Range:
$104.71
$124.50
52-Week Range:
$55.00
$177.37
Transmedics Group Inc Stock (TMDX) Company Profile
Name
Transmedics Group Inc
Sector
Industry
Phone
(978) 552-0900
Address
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
118.97 | 3.64B | 401.09M | 32.64M | -120.51M | 0.94 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-22-24 | Downgrade | Needham | Buy → Hold |
| Oct-29-24 | Reiterated | Needham | Buy |
| Oct-29-24 | Reiterated | Oppenheimer | Outperform |
| Sep-24-24 | Initiated | Robert W. Baird | Outperform |
| Aug-21-24 | Initiated | Needham | Buy |
| Jun-06-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-24 | Initiated | Stephens | Overweight |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Aug-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| May-28-19 | Initiated | Canaccord Genuity | Buy |
| May-28-19 | Initiated | Cowen | Outperform |
| May-28-19 | Initiated | JP Morgan | Overweight |
| May-28-19 | Initiated | Morgan Stanley | Equal-Weight |
View All
Transmedics Group Inc Stock (TMDX) Latest News
Why TransMedics Stock Is Skyrocketing Today - The Globe and Mail
TransMedics revenue up 38% to USD 157.4M in Q2 2025 - Medical Buyer
TransMedics: Q2 Earnings Snapshot - CTPost
Has TransMedics Group Inc. found a price floorLow Volatility Stock Analysis With Confidence - Newser
TransMedics (TMDX) Q2 Revenue Jumps 38% - The Motley Fool
TransMedics Group 2025 Q2 Earnings Beats Expectations as Net Income Soars 186% - AInvest
Applying Wyckoff theory to TransMedics Group Inc. stockStock Performance Summary Over One Year - Newser
TransMedics Raises Outlook After Strong Quarter And Growing Demand - Finimize
What are the latest earnings results for TransMedics Group Inc.Beginner Investor Planner With High Returns - jammulinksnews.com
TransMedics Group Inc (TMDX) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
When is the best time to buy TransMedics Group Inc. stockLong Term Stock Planner with Safety Checks - Newser
Baillie Gifford & Co. Sells 10,159 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
What analysts say about TransMedics Group Inc. stock outlookFree Conservative Entry for High Return Setup - Newser
TransMedics Sees Its Earnings Soar - AOL.com
TransMedics Reports Strong Q2 2025 Financial Results - TipRanks
Can trapped investors hope for a rebound in TransMedics Group Inc.5-Year Price Trend Summary and Analysis - Newser
Using Bollinger Bands to evaluate TransMedics Group Inc.Daily Pattern Analysis with Return Forecast - Newser
How strong is TransMedics Group Inc. company’s balance sheetAI Powered Picks For Fast Growth - jammulinksnews.com
Bastion Asset Management Inc. Has $330,000 Stake in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Earnings call transcript: TransMedics beats Q2 2025 expectations with strong revenue By Investing.com - Investing.com South Africa
Earnings call transcript: TransMedics beats Q2 2025 expectations with strong revenue - Investing.com
TransMedics (TMDX) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
TransMedics Group Stock Jumps On Q2 Earnings Beat, Company Raises 2025 Outlook - Benzinga
TransMedics (TMDX) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
TransMedics shares soar as Q2 earnings double analyst estimates - Investing.com Australia
Transmedics Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
TransMedics Reports Second Quarter 2025 Financial Results - PR Newswire
Should you hold or exit TransMedics Group Inc. nowEquity Signal Recap With Long-Term Summary - Newser
Why TransMedics Group Inc. stock attracts strong analyst attentionProfitable Trading Blueprint with Entry Zones - Newser
Published on: 2025-07-30 01:19:32 - Newser
Will TransMedics Group Inc. outperform the marketFree Quick Gain Stock Watch With Indicators - Newser
4,930 Shares in TransMedics Group, Inc. (NASDAQ:TMDX) Bought by Legato Capital Management LLC - MarketBeat
Momentum divergence signals in TransMedics Group Inc. chartFree Reliable Investment Entry Point Signals - Newser
TransMedics to Present at the Canaccord Genuity 45th Annual Growth Conference - cnhinews.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Investors to Reach Out - ACCESS Newswire
Earnings To Watch: TransMedics Group Inc (TMDX) Reports Q2 2025 Result - GuruFocus
Using data filters to optimize entry into TransMedics Group Inc.Buy Opportunity Forecast for Fast Traders - Newser
TransMedics Group Inc. Sees Relief Buying After Extended DropAI Driven Buy Alert Trade Blueprint Released - metal.it
Order flow analysis tools used on TransMedics Group Inc.Free Value Investing Picks With Stability - Newser
Countdown to TransMedics (TMDX) Q2 Earnings: Wall Street Forecasts for Key Metrics - Yahoo Finance
What is the risk reward ratio of investing in TransMedics Group Inc. stockBuild wealth with reliable stock picks - jammulinksnews.com
Is TransMedics Group Inc. stock overvalued or undervaluedAchieve breakthrough profits with smart strategies - jammulinksnews.com
TransMedics Group (TMDX) to Release Quarterly Earnings on Wednesday - Defense World
TransMedics Group Sees IBD RS Rating Climb To 74 - Investor's Business Daily
TransMedics Group TMDX 2025Q2 Earnings Preview Upside Potential Driven by Robust Revenue Growth - AInvest
Should I hold or sell TransMedics Group Inc. stock in 2025Tremendous wealth creation - jammulinksnews.com
What are analysts’ price targets for TransMedics Group Inc. in the next 12 monthsAchieve breakthrough profits with smart strategies - jammulinksnews.com
What institutional investors are buying TransMedics Group Inc. stockTriple-digit return opportunities - jammulinksnews.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Reach Out - ACCESS Newswire
Transmedics Group Inc Stock (TMDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):